Kazuya Shimura

Kyoto, 6068507, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence.

Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 20, 2021

Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19.

Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19.

Journal: Cell reports

Published: March 13, 2021

Synergistic inhibition of cell-to-cell HIV-1 infection by combinations of single chain variable fragments and fusion inhibitors.

Synergistic inhibition of cell-to-cell HIV-1 infection by combinations of single chain variable fragments and fusion inhibitors.

Journal: Biochemistry and biophysics reports

Published: June 18, 2019

Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells.

Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 24, 2018

Correction: HTLV-1 bZIP Factor Enhances T-cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors.

Correction: HTLV-1 bZIP Factor Enhances T-cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors.

Journal: PLoS pathogens

Published: February 24, 2017

HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors.

HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors.

Journal: PLoS pathogens

Published: July 30, 2016

Enhanced antibody-mediated neutralization of HIV-1 variants that are resistant to fusion inhibitors.

Enhanced antibody-mediated neutralization of HIV-1 variants that are resistant to fusion inhibitors.

Journal: Retrovirology

Published: May 19, 2016

Impact of HIV-1 infection pathways on susceptibility to antiviral drugs and on virus spread.

Impact of HIV-1 infection pathways on susceptibility to antiviral drugs and on virus spread.

Journal: Virology

Published: May 23, 2015

Investigations of possible prodrug structures for 2-(2-mercaptophenyl)tetrahydropyrimidines: reductive conversion from anti-HIV agents with pyrimidobenzothiazine and isothiazolopyrimidine scaffolds.

Investigations of possible prodrug structures for 2-(2-mercaptophenyl)tetrahydropyrimidines: reductive conversion from anti-HIV agents with pyrimidobenzothiazine and isothiazolopyrimidine scaffolds.

Journal: Organic & biomolecular chemistry

Published: March 25, 2015

Identification of anti-HIV agents with a novel benzo[4,5]isothiazolo[2,3-a]pyrimidine scaffold.

Identification of anti-HIV agents with a novel benzo[4,5]isothiazolo[2,3-a]pyrimidine scaffold.

Journal: Bioorganic & medicinal chemistry

Published: January 23, 2015

HIV-1 resistance mechanism to an electrostatically constrained peptide fusion inhibitor that is active against T-20-resistant strains.

HIV-1 resistance mechanism to an electrostatically constrained peptide fusion inhibitor that is active against T-20-resistant strains.

Journal: Antimicrobial agents and chemotherapy

Published: May 22, 2013

Structure-activity relationship study of phenylpyrazole derivatives as a novel class of anti-HIV agents.

Structure-activity relationship study of phenylpyrazole derivatives as a novel class of anti-HIV agents.

Journal: Bioorganic & medicinal chemistry letters

Published: May 15, 2013

Showing 1-12 of 19

Last Updated: 09/26/2026